Earnings History Data for Milestone Pharmaceuticals (MIST) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals Inc. is based in Montr?al, Canada.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
21-03-2024	PM		MIST	Milestone Pharmaceuticals	49.00	-0.32	-0.30	0.00	Milestone Pharmaceuticals reports Q4 results [3/21/2024 12:32 PM]	1.55	0.05 (3.64%)	1.53	0.03 (2.00%)	1.33 - 4.49	298,502	270,000	301
Milestone Pharmaceuticals reports Q4 results [3/21/2024 12:32 PM]
13-11-2023	PM		MIST	Milestone Pharmaceuticals	98.00	-0.35	-0.38	0.00	Milestone Pharmaceuticals GAAP EPS of -$0.35 beats by $0.03 [11/13/2023 6:58 AM]	2.35	-0.56 (-19.24%)	2.96	0.05 (1.72%)	2.19 - 5.20	424,611	100,000	39,700
Milestone Pharmaceuticals GAAP EPS of -$0.35 beats by $0.03 [11/13/2023 6:58 AM]
10-08-2023	PM		MIST	Milestone Pharmaceuticals Inc.	98.41	-0.37	-0.39	-0.39	Milestone Pharmaceuticals GAAP EPS of -$0.37 beats by $0.02 [8/10/2023 12:24 PM]	3.13	-0.17 (-5.15%)	3.26	-0.04 (-1.21%)	2.73 - 9.85	75,292	220,000	2,452
Milestone Pharmaceuticals GAAP EPS of -$0.37 beats by $0.02 [8/10/2023 12:24 PM]
29-03-2023	AH		MIST	Milestone Pharmaceuticals Inc.	116.23	-0.31	-0.35	-0.40	Milestone Pharmaceuticals GAAP EPS of -$0.31, revenue of $3.5M [3/29/2023 4:59 PM]	3.89	-0.01 (-0.26%)	0.0	0.0 (0.00%)	3.10 - 9.85	120,809	200,000	0
Milestone Pharmaceuticals GAAP EPS of -$0.31, revenue of $3.5M [3/29/2023 4:59 PM]
10-11-2022	PM	Before the open (Nov 10)	MIST	Milestone Pharmaceuticals	127.00	-0.34	-0.41	0.00	Milestone Pharmaceuticals GAAP EPS of -$0.34 beats by $0.07, revenue of $1.5M [11/10/2022 9:10 AM]	4.49	0.40 (9.66%)	0.0	0.0 (0.00%)	3.98 - 9.85	697,239	870,000	0
Milestone Pharmaceuticals GAAP EPS of -$0.34 beats by $0.07, revenue of $1.5M [11/10/2022 9:10 AM] Milestone Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Corporate Update [Nov-10-22 07:21AM]
12-05-2022	PM	7:20 AM ET (May 12)	MIST	Milestone Pharmaceuticals	166.00	-0.33	-0.39	0.00	Milestone Pharmaceuticals GAAP EPS of -$0.33 [5/12/2022 8:18 AM]	5.13	-0.41 (-7.40%)	0.0	0.0 (0.00%)	3.98 - 8.24	68,528	50,000	0
Milestone Pharmaceuticals GAAP EPS of -$0.33 [5/12/2022 8:18 AM] Milestone Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Corporate Update [May-12-22 07:15AM]
17-05-2021	PM		MIST	Milestone Pharmaceuticals Inc.	157.00	-0.30	-0.33	0.00	Milestone Pharmaceuticals EPS beats by $0.03 [5/17/2021 7:37 AM]	5.64	0.09 (1.62%)	5.56	0.01 (0.18%)	3.08 - 11.40	85,016	50,000	3,454
Milestone Pharma reports etripamil data in late-stage paroxysmal supraventricular tachycardia study [5/17/2021 7:51 AM] Milestone Pharmaceuticals EPS beats by $0.03 [5/17/2021 7:37 AM] Milestone Pharma inks etripamil development deal for PSVT in Greater China [5/17/2021 10:02 AM] Milestone Pharmaceuticals Announces Late-Breaker Oral Presentation of NODE-301 Data at ACC.21 [May-17-21 07:02AM] Milestone Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical, Regulatory, and Corporate Update [May-17-21 07:01AM] Milestone Pharmaceuticals Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China [May-17-21 07:00AM] Milestone Pharma-Ji Xing Pharma Ink $127M Etripamil Development Agreement For China [May-17-21 01:22PM]
13-11-2020	PM		MIST	Milestone Pharmaceuticals Inc.	159.00	-0.40	-0.49	0.00	Milestone Pharmaceuticals EPS beats by $0.09 [11/13/2020 7:23 AM]	6.31	0.11 (1.77%)	6.11	-0.09 (-1.45%)	1.69 - 23.24	143,065	107,851	571

12-08-2020	PM		MIST	Milestone Pharmaceuticals Inc.	241.33	-0.53	-0.47	-1.04	Milestone Pharmaceuticals EPS misses by $0.06 [8/12/2020 7:06 AM]	8.39	-0.51 (-5.73%)	9.34	0.44 (4.94%)	1.69 - 24.01	282,765	1,453,880	3,550